Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PBYI · against 588 other Healthcare companies listed in US-listed
Ranked #60 of 589 · scores higher than 90% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 70–79, including PBYI · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | PBYI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 5.0% | -4.3% | 89% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 9.1% | -0.8% | 85% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 7.8% | -2.3% | 91% | 20% | |
| Book yieldHigher is better · 587 reported | 26.5% | 25.9% | 51% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 56 | 418M USD | 79 | 74 | |
| 58 | 393M USD |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 78 |
| 61 |
| 59 | 10.7B USD | 77 | 78 |
| 60 | 89.7B USD | 76 | 50 |
| 60 | 528M USD | 76 | 58 |
| 62 | 2.3B USD | 75 | 74 |
| 62 | 38.9B USD | 75 | 56 |
| 62 | 1.8B USD | 75 | 80 |
| 62 | 107M USD | 75 | 31 |